Skip to main content
Seegnal logo

Seegnal — Investor Relations & Filings

Ticker · SEGN ISIN · CA81573E1060 TSXV Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 102 across all filing types
Latest filing 2025-07-30 Regulatory Filings
Country CA Canada
Listing TSXV SEGN

About Seegnal

https://www.seegnal.com/

Seegnal is a healthcare technology provider specializing in SaaS clinical decision support solutions, marketed as the enterprise Prescription Operating System (Prescription OS). The platform's core function is to mitigate Adverse Drug Effects (ADEs) and reduce patient risk by enabling precision prescribing. Seegnal continuously analyzes prescribing decisions in real-time, leveraging comprehensive clinical context, including patient medications, diagnoses, and lab results. This system delivers measurable clinical ROI and significantly reduces alert fatigue, reportedly lowering alert load by up to 94%. Key modules, such as Seegnal Guard and MetricsGuard, provide real-time, explainable alerts, empowering clinicians while ensuring that all final prescribing decisions remain fully under their control.

Recent filings

Filing Released Lang Actions
Consent letter of issuer's legal counsel.pdf
Regulatory Filings Classification · 1% confidence The document is a legal consent letter from a law firm to Canadian securities regulators permitting use of its name and opinion in a prospectus. It is not the prospectus itself nor an earnings, annual, or proxy document, and it does not announce dividends, management changes, or share transactions. It is a regulatory submission that does not fit other specific categories, so it falls under the general Regulatory Filings (RNS) category.
2025-07-30 English
Final long form prospectus - English.pdf
Regulatory Filings Classification · 1% confidence The document is a detailed “Final Prospectus” filed under TSXV rules by a capital pool company to complete its Qualifying Transaction. It is not a management discussion, earnings release, proxy statement, director change announcement, or other specifically defined report. There is no standalone category for a securities prospectus in the taxonomy, so this long-form regulatory disclosure falls under the fallback category for miscellaneous regulatory filings. Therefore, it should be classified as a Regulatory Filing (RNS).
2025-07-30 English
Material change report - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a Canadian securities filing titled “Form 51-102F3 Material Change Report,” filed on SEDAR+, which provides a detailed description of non-brokered private placements, subscription receipts, gross proceeds, escrow release conditions, finders’ fees and post-transaction capitalization. It is clearly an update concerning the company’s fundraising and capital structure changes rather than an earnings release, annual report, or board change. This aligns with the “Capital/Financing Update” category (Code: CAP).
2025-07-07 English
Decision Document (Amendment to Preliminary).pdf
Regulatory Filings Classification · 1% confidence The document is a formal regulatory receipt issued by the Alberta Securities Commission (and Ontario Securities Commission) for a Non-Offering Amended and Restated Preliminary Long Form Prospectus. It is not the prospectus itself, nor a company earnings report or management presentation. It serves as a regulatory filing confirming acceptance of a prospectus. Therefore, it falls under the fallback category “Regulatory Filings” with code RNS.
2025-06-28 English
Amendment to (or amended) preliminary long form prospectus - English.pdf
M&A Activity Classification · 1% confidence The document is an amended and restated preliminary prospectus filed under Canadian securities laws to enable a capital pool company (Reem Capital Corp.) to complete its Qualifying Transaction (a reverse take-over / acquisition of Kalron Holdings Ltd.). It is not an annual or interim report, nor a simple regulatory notice; rather, it is the primary transaction document for an M&A deal. It clearly describes the terms of the acquisition, the share adjustments, private placements, and result of the proposed transaction. Therefore, it best fits the definition of M&A Activity (Code: TAR).
2025-06-28 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a notice from TSX Trust Company confirming that the record and meeting dates for an upcoming Annual General and Special Meeting have been sent to the Canadian Depository for Securities. It does not provide AGM materials, proxy statements, financial results, or any other specific report; it is a routine regulatory announcement. None of the more specific categories (AGM materials, proxy materials themselves, dividend notice, earnings release, etc.) apply. Therefore, it falls into the fallback category for general regulatory announcements.
2025-06-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.